Several reports demonstrated a close correlation between serum levels of CHI3L1 and severity of hepatic fibrosis in NAFLD [11–13], viral hepatitis [14–16], and ALD [17]. Here, CHI3L1 is linked to metabolic dysfunction-associated steatotic liver disease.